Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Intermediate
2-(Methoxy(4-phenoxyphenyl)methylene)malononitrile serves as a vital drug intermediate in the synthesis of diverse active pharmaceutical ingredients. This compound facilitates the development of novel therapeutics by providing a versatile scaffold for further chemical modifications. Its role is crucial in advancing research in medicinal chemistry and drug discovery. -
Drug Intermediate
6-Hydrazinyl-3-methylpyrimidine-2,4(1H,3H)-dione is a versatile drug intermediate known for its role in the synthesis of various biologically active compounds. It serves as a crucial building block in medicinal chemistry, facilitating the development of novel pharmaceuticals and therapeutic agents. Its unique structure enables researchers to explore a wide range of applications in drug discovery and development. -
Drug Intermediate
2-Amino-4-(1-adamantyl)thiazole is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound plays a critical role in the development of various bioactive molecules. Its unique structural attributes make it a valuable building block for researchers engaged in medicinal chemistry and drug discovery efforts. -
Drug Intermediate
2,5-Dimethoxybenzoic acid serves as a key intermediate in the synthesis of the galbulimima alkaloid GB 13. Its unique chemical structure facilitates various synthetic pathways in organic chemistry. This compound is primarily utilized in research focused on alkaloid production and pharmaceutical development, providing valuable insights into potential therapeutic applications. -
Drug Intermediate
1-Adamantylcarbinyl iodide serves as a crucial drug intermediate in the synthesis of diverse bioactive compounds. Its structural features facilitate the development of novel pharmaceuticals, particularly in medicinal chemistry. This compound is valuable for researchers aiming to explore new therapeutic agents and optimize existing drug candidates. -
Drug Intermediate
Octahydrocyclopenta[c]pyrrole is an organic compound utilized as a drug intermediate with diverse biological activities. It has demonstrated potential in anti-inflammatory, anti-tumor, and neuroprotective applications. The compound's unique structure-activity relationship offers valuable insights for the design and development of novel therapeutic agents. -
Drug Intermediate
5-((6-Chlorohexyl)oxy)pentan-1-ol serves as a vital drug intermediate in the synthesis of diverse active pharmaceutical compounds. This reagent is instrumental in facilitating the construction of complex molecular architectures, contributing to the development of new therapeutic agents. Its versatile chemical properties make it a valuable tool in medicinal chemistry research and development. -
Drug Intermediate
1,3-Distearin, also known as 1,3-Distearoyl glycerol, serves as a crucial intermediate in the synthesis of non-steroidal anti-inflammatory agents. It is utilized in the production of drugs such as Ibuprofen, Naproxen, and Diclofenac, contributing to the development of therapeutic compounds for pain and inflammation management. This reagent is essential for research focused on drug synthesis and formulation in pharmacological studies. -
Drug Intermediate
3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonyl fluoride serves as a versatile drug intermediate, facilitating the synthesis of diverse bioactive compounds. Its unique structural features enable efficient incorporation into complex chemical pathways, aiding in the development of pharmaceutical agents. This reagent is particularly valuable in medicinal chemistry and related research applications for the creation of sulfonamide derivatives and other functionalized molecules. -
Drug Intermediate
O-Acetyl-L-homoserine hydrochloride serves as a crucial intermediate in the biosynthesis of L-Methionine. It functions as an inhibitor of OAH sulfhydrylase (CaMet15p), impacting methionine metabolic pathways. This compound is primarily utilized in biochemical research focused on amino acid synthesis and enzyme inhibition studies. -
Drug Intermediate
2-Pyrimidineacetic acid serves as a versatile synthetic intermediate in pharmaceutical synthesis. This compound is utilized in the preparation of various bioactive molecules and can facilitate the development of therapeutic agents. Its role in drug discovery research highlights its importance in medicinal chemistry and related fields. -
Drug Intermediate
3-Methoxybenzothioamide is a chemical intermediate that exhibits notable reactivity in drug synthesis. This compound serves as a valuable building block in pharmaceutical research, facilitating the development of novel therapeutic agents. Its unique structural properties contribute to its utility in various chemical transformations necessary for creating diverse drug candidates. -
Drug Intermediate
tert-Butyl (4-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)butyl)carbamate serves as a critical drug intermediate in organic synthesis. This compound facilitates the formation of diverse bioactive molecules, playing an essential role in the development of pharmaceuticals targeting various biological pathways. Its unique structure allows for further functionalization, making it a valuable reagent in medicinal chemistry and drug discovery research. -
Drug Intermediate
DM-CO-(CH2)5-SH is a valuable drug intermediate utilized in the synthesis of antibody-drug conjugate (ADC) metabolites. This compound enables researchers to explore the pharmacokinetics and efficacy of ADCs in targeted cancer therapies. Its role as a synthetic building block makes it essential for advancing drug development and optimizing therapeutic strategies in chemical research. -
Drug Intermediate
tert-Butyl (4-((5-fluoro-7-(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)carbamate serves as a critical drug intermediate in the synthesis of diverse bioactive compounds. This compound's structure is integral for the development of pharmaceuticals targeting specific molecular pathways. Its applications in medicinal chemistry support the design and evaluation of potential therapeutic agents. -
Drug Intermediate
5,6-Dimethoxyindan-1-one is a versatile drug intermediate employed in the synthesis of diverse active pharmaceutical ingredients. It has applications in the development of antiviral compounds and acetylcholinesterase butyrylcholinesterase inhibitors. This reagent serves as a critical building block in medicinal chemistry, facilitating the exploration of new therapeutic agents. -
Drug Intermediate
7(Z),10(Z),13(Z)-Hexadecatrienoic acid, also known as Roughanic acid, functions as a drug intermediate in organic synthesis. This ω-3 polyunsaturated fatty acid (PUFA), extracted from the leaves of S. olusatrum, plays a crucial role in the biosynthesis of jasmonic acid. Its applications in chemical research chiefly involve the investigation of plant hormone pathways and the exploration of bioactive lipid compounds in various biological systems. -
Drug Intermediate
Triacetylphloroglucinol is a symmetric three-dimensional bridged ligand that serves as a useful drug intermediate in organic synthesis. It facilitates the production of various compounds, including trinuclear vanadium Schiff base complexes, copper complexes, and anthelmintics. Its applications extend to the development of pharmacologically relevant materials and coordination chemistry. -
Drug Intermediate
3-(2-Chloroacetyl)-1H-indole-5-carbonitrile serves as an important drug intermediate, facilitating the synthesis of diverse active pharmaceutical compounds. This compound is characterized by its unique indole structure, which contributes to its utility in medicinal chemistry research. Its versatility in organic synthesis makes it a valuable reagent for developing new therapeutic agents. -
Drug Intermediate
(Z)-5-(4-Iodobenzylidene)-2-thioxothiazolidin-4-one serves as a crucial drug intermediate in the synthesis of diverse active pharmaceutical compounds. This compound exhibits structural characteristics that facilitate various chemical reactions, making it valuable in medicinal chemistry research. Its applications extend to the development of novel therapeutic agents with potential biological activity. -
Drug Intermediate
Cyanoacetohydrazide serves as a pharmaceutical intermediate, primarily utilized in the synthesis of acylhydrazide hydrazone derivatives. These derivatives have demonstrated notable antibacterial and anti-tumor activities, making cyanoacetohydrazide a valuable compound in drug development and medicinal chemistry research. Its versatile applications in synthesizing bioactive compounds contribute significantly to advancing therapeutic strategies. -
Drug Intermediate
3-(4-Chlorophenoxy)-4-methylaniline serves as a critical drug intermediate utilized in the synthesis of a range of active pharmaceutical ingredients. This compound is integral in the development of various therapeutic agents, enabling effective chemical transformations in medicinal chemistry. Its unique structural features allow for versatile applications in pharmaceutical research and development. -
Drug Intermediate
2,3,4-Tri-O-acetyl-β-D-glucuronide methyl ester is a synthetic intermediate utilized in the preparation of prodrug forms of the antitumor antibiotic Daunomycin. This compound exhibits crucial functionalities in glycosylation reactions, facilitating drug development and optimization. Its applications in medicinal chemistry and pharmaceutical research make it a valuable reagent for advancing therapeutic formulations in oncology research. -
Drug Intermediate
42-O-(2-Azidoethyl)-Rapamycin is an azide-modified derivative of Rapamycin, functioning as an important drug intermediate for synthetic applications. It facilitates the development of Rapamycin derivatives, which are of interest in various therapeutic contexts, particularly in cancer research and immunosuppression studies. This compound's unique structure allows for further modifications that can enhance biological activity and specificity in target engagement. -
Drug Intermediate
Methyl (3S,6R)-6-methyl-3-piperidinecarboxylate L-tartaric acid salt serves as a versatile drug intermediate in the synthesis of various bioactive compounds. This compound plays a crucial role in the preparation of pharmaceutical agents, contributing to diverse chemical structures and medicinal properties. Its application is significant in the fields of medicinal chemistry and drug development. -
Drug Intermediate
6,7-Dibromoquinoline-5,8-dione is a versatile drug intermediate utilized in the synthesis of a variety of biologically active compounds. This compound serves as a crucial building block in medicinal chemistry and pharmaceutical development, facilitating the creation of novel therapeutic agents. Its incorporation into chemical reactions can lead to the development of compounds with potential applications in diverse areas of drug discovery and development. -
Drug Intermediate
Triphenylene is a highly symmetrical polycyclic aromatic hydrocarbon that serves as a valuable drug intermediate. It facilitates the synthesis of triphenyl polycyclic aromatic hydrocarbons (PAHs), which are significant in various chemical applications. Notably, Triphenylene demonstrates no carcinogenic activity in mouse skin application experiments, supporting its use in safe pharmaceutical development and research. -
Drug Intermediate
4-Methylbenzothioamide is a cyclic thioamide used as a building block in drug discovery chemistry. This compound serves as an important intermediate in the synthesis of various pharmaceutical agents. Its unique structure allows for the modification of bioactive molecules, facilitating the development of novel therapeutics. -
Drug Intermediate
N,N-Dimethyl-L-valine is a synthetic amino acid derivative commonly used as a drug intermediate in pharmaceutical synthesis. This compound serves as a valuable building block in the development of various bioactive molecules, facilitating the creation of novel therapeutic agents. Its structural properties contribute to the modulation of biological activity, making it an essential reagent in chemical research and drug discovery applications. -
Drug Intermediate
tert-Butyl chlorosulfonylcarbamate compound with 1,4-diazabicyclo[2.2.2]octane (1:2) serves as a versatile drug intermediate, facilitating the synthesis of a range of bioactive molecules. This compound is particularly useful in the development of pharmaceuticals due to its ability to participate in multistep synthesis reactions, enhancing chemical pathways for novel drug discovery and development. Its unique structure enables precise functionalization, making it an essential reagent in chemical research and medicinal chemistry applications. -
Drug Intermediate
2,2-Dibenzyl-1,3-propanediol serves as a crucial drug intermediate in the synthesis of various pharmacologically active compounds. It contributes to the formation of complex molecular structures, facilitating the development of new therapeutics. This compound is valuable in medicinal chemistry and drug development applications, where it supports the exploration of innovative treatments. -
Drug Intermediate
Methyl 9H-xanthene-9-carboxylate serves as a crucial intermediate in the synthesis of diverse active pharmaceutical compounds. This compound plays an essential role in the development of xanthene derivatives, which are of significant interest in chemical and medicinal research. Its utility in drug synthesis supports studies aimed at optimizing pharmacological properties and biological activities. -
Drug Intermediate
4-Chlorophenyl-2-pyridinylmethanol is a versatile synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound acts as a building block in the development of various bioactive molecules, facilitating the production of targeted therapeutics. Its efficacy in chemical reactions makes it a valuable reagent for researchers engaged in drug discovery and development. -
Drug Intermediate Control
2-Pyrimidinepropanoic acid is a synthetic intermediate primarily utilized in pharmaceutical synthesis. This compound serves as a key building block in the development of various bioactive molecules and drug candidates, facilitating research in medicinal chemistry. Its role in the modification of bioactive compounds makes it valuable for applications in drug discovery and development. -
MRX-I Prodrug Intermediate
Contezolid phosphoramidic acid is a key intermediate in the synthesis of MRX-I, an antibacterial oxazolidinone agent. This compound plays a critical role in the development of proagents designed to combat bacterial infections. Its relevance in medicinal chemistry makes it an essential reagent for research applications focused on antibiotic efficacy and development. -
Drug Intermediate
5-Ethoxy-4-methyloxazole is a chemical intermediate primarily utilized in the synthesis of pharmaceutical compounds. This heterocyclic compound contributes to the development of various drug candidates by serving as a building block in organic synthesis. Its structural characteristics support research in medicinal chemistry and the design of novel therapeutics. -
Drug Intermediate
tert-Butyl 2-(5-chloro-2,2'-dioxospiro[indole-3,3'-pyrrolidine]-1-yl)acetate serves as an important intermediate in the synthesis of potent DP2 receptor antagonists derived from a novel spiro-indolinone framework. This compound is significant for its role in drug discovery, particularly in the development of therapeutics aimed at modulating immune responses and inflammation pathways. Researchers utilize this intermediate to facilitate the creation of compounds with potential clinical applications in treating allergic and inflammatory diseases. -
Drug Intermediate
Stemmadenine is a strychnos-type monoterpenoid indole alkaloid that functions as a crucial biosynthetic precursor in the formation of monoterpenoid indole alkaloid structures. Its primary mechanism involves contributing to the synthesis of complex alkaloids, making it valuable in drug development and research into natural product synthesis. Stemmadenine is utilized extensively in studies focused on the biosynthetic pathways of alkaloids and their potential therapeutic applications. -
Drug Intermediate
(2R,3S,4R,5R)-GlcAc-GlcA is a hexose derivative primarily utilized as a drug intermediate in the synthesis of antibody-drug conjugate (ADC) linkers. Its structural features contribute to the development of more effective targeted therapies in oncology research. This compound serves as a valuable building block in the formulation of bioconjugates, enhancing the specificity and efficacy of therapeutic agents. -
Drug Intermediate
2-Phenylacrylonitrile is a versatile pharmaceutical intermediate that serves as a precursor in the synthesis of various compounds. Its derivatives are utilized in cancer research, particularly in the development of cancer therapeutics and mechanisms of action studies. This compound provides essential building blocks for the exploration of anticancer agents and their biological activity. -
Drug Intermediate
Fmoc-PNA-maleimide-OH is a Fmoc-protected peptide nucleic acid monomer that incorporates a maleimide moiety, enabling selective thiol-reactive conjugation. This compound facilitates the construction of peptide nucleic acid (PNA) conjugates, which are valuable in molecular assembly and bioconjugation applications. Its unique functionalization allows for enhanced versatility in the design of nucleic acid-based tools for research and therapeutic development. -
Drug Intermediate
Erlotinib lactam impurity is a chemical precursor of the tyrosine kinase inhibitor erlotinib. This compound serves as an important intermediate in the synthesis of anti-cancer therapeutics, particularly in the study of targeted therapies for non-small cell lung cancer. Its role in drug development makes it a valuable reagent for research applications focused on kinase inhibition and related signaling pathways. -
Drug Intermediate
3-(Trimethylsilyl)-1-propanesulfonic acid sodium functions as a drug intermediate, facilitating various chemical reactions. This compound serves as a versatile reagent in the synthesis of peptides, proteins, and nucleic acids. Its efficacy in stabilizing reactive intermediates makes it a valuable tool for researchers in biochemical and pharmaceutical applications. -
Drug Intermediate
5-Br-4-Cl-Pyrrolo-pyroxypyridine serves as a synthetic intermediate for molecular glues. It is particularly relevant in the synthesis of GSPT1 degrader-9, facilitating targeted protein degradation. This compound is essential for research applications focused on proteostasis and the modulation of protein interactions. -
Drug Intermediate
4-Hydroxy-3,3-dimethylcyclohexanone serves as a crucial intermediate in the synthesis of human acetylcholinesterase (hAChE) inhibitors. Its role in the development of hAChE inhibitors makes it significant for research in neuropharmacology and disease models related to cholinergic dysfunction. This compound's unique structural properties facilitate the exploration of therapeutic agents targeting cognitive disorders. -
Drug Intermediate
H-Aeg(Fmoc)-OBzl hydrochloride is an Fmoc-protected aminoethylglycine derivative with a benzyl ester moiety. It serves as a versatile drug intermediate, facilitating the synthesis of peptide nucleic acids and protected oligomers. This compound is valuable in various research applications, including peptide synthesis and molecular biology studies. -
Drug Intermediate
LY280748 is a potent imidazolate receptor ligand, functioning primarily as a drug intermediate. This compound exhibits significant biological activity, making it a valuable tool in pharmacological research and development. Its application spans various studies focused on receptor-mediated signaling pathways and the synthesis of novel therapeutic agents. -
Drug Intermediate
GA44 is a C20-gibberellin that serves as an intermediate in the early 13-hydroxylation pathway of gibberellin biosynthesis. This compound plays a critical role in the synthesis of biologically active gibberellins, which are important regulators of plant growth and development. GA44 is utilized in research applications focusing on plant hormone signaling and metabolism studies. -
Drug Intermediate
H-Aeg(Fmoc)-OH hydrochloride is an Fmoc-protected aminoethylglycine monomer that features a free carboxyl group. This reagent serves as a versatile building block for peptide nucleic acid synthesis, facilitating the construction of PNA oligomers. Its chemical structure supports the incorporation of aminoethylglycine into various bioconjugates, making it valuable in nucleic acid research and related fields. -
Drug Intermediate
N,N'-bis-Cbz-β-Alethine is an active ester that serves as a crucial intermediate in the synthesis of β-alethine. β-Alethine has been shown to induce cell differentiation and exhibits potential anti-tumor properties. The conversion of N,N'-bis-Cbz-β-Alethine to β-alethine is achieved through the removal of the carbobenzoxy (CBZ) groups using hydrogen bromide in glacial acetic acid. This compound is valuable for research focused on cell differentiation mechanisms and anti-cancer drug development.
